GeneFab

GeneFab

Overview

About GeneFab

Simplify's Rating
Why GeneFab is rated
D+
Rated C on Competitive Edge
Rated D+ on Growth Potential
Rated D+ on Differentiation

Industries

Industrial & Manufacturing

Biotechnology

Healthcare

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • RegCell partnership accelerates U.S. clinical trials for autoimmune hepatitis.
  • Alameda expansion adds 45,000 sq ft for pivotal trials by 2026.
  • ASGCT 2024 presentations showcase GeneFab's genetic design leadership.

What critics are saying

  • RegCell terminates GeneFab partnership, shifts to Kincell Bio in February 2026.
  • Kincell Bio partnership erodes GeneFab's RegCell manufacturing revenue immediately.
  • Lonza and Thermo Fisher capture GeneFab's clients within 12-18 months.

What makes GeneFab unique

  • GeneFab provides end-to-end CRDMO services for Treg therapies at Alameda facility.
  • 92,000 sq ft site features seven GMP clean rooms for tech transfer and scale-up.
  • Synthetic biology expertise enables co-development of next-gen Treg therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Flexible Work Hours

Hybrid Work Options

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Paternity Leave

Maternity Leave

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Parental Leave

Relocation Assistance

Meal Benefits

Employee Referral Bonus

Tuition Reimbursement

Legal Services

Childcare Support

Elder Care Support

Gym Membership

Commuter Benefits

Performance Bonus

Profit Sharing

Employee Stock Purchase Plan

Training Programs

Tuition Reimbursement

Company News

Contract Pharma
May 7th, 2025
GeneFab & RegCell Partner for Treg Therapy Manufacturing in the U.S.

GeneFab, a cell and gene therapy-focused contract research, development, and manufacturing organization (CRDMO), has partnered with RegCell, a biotech company advancing regulatory T cell (Treg) therapies for autoimmune diseases, to support the tech transfer and clinical manufacturing of RegCell's Treg platform as it transitions from Japan to GeneFab's manufacturing facility in Alameda.

Recently Posted Jobs

Sign up to get curated job recommendations

GeneFab is Hiring for 7 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →